Bacteremia is a leading cause of death in developing countries but etiologic evaluation is infrequent and empiric antibiotics are not evidence-based. Very little is known about the types of extended-spectrum β-lactamases (ESBL) in pediatric bacteremia patients in Nigeria. We evaluated the patterns of ESBL resistance in children enrolled into surveillance for community acquired bacteremic syndromes across health facilities in Central and Northwestern Nigeria.
Introduction
Bacterial blood stream infection (BSI) is a major public-health concern especially in developing countries as it is one of the leading causes of death. In Nigeria as in most developing countries, sub optimal laboratory methods contribute to improper diagnosis of BSI in children [1] . The absence of etiologic diagnosis and clinical microbiology laboratories implies that patients are often treated with broad spectrum antibiotics. This unguided approach to clinical care promotes the incidence of drug resistant bacteria.
Antibiotic resistance has become a concern worldwide and in Enterobacteriaceae, the production of β-lactamase remains the most important mediator of β-lactam resistance [2] . Extended-spectrum β-lactamases (ESBLs) are a rapidly evolving group of β-lactamases which hydrolyze the extended-spectrum cephalosporins, the penicillins, as well as aztreonam, but not carbapenems [3] .
These ESBL-producing bacteria are also resistant to other class of antimicrobial agents such as aminoglycosides, trimethoprim/sulfamethoxazole, and quinolones thereby leading to Multidrugresistance (MDR), which often complicate the treatment of severe bacterial infections [2, 4, 5] . The World Health Organization (WHO) has declared infections caused by multidrug resistant bacteria as an emerging global health problem of major public health concern [6].
The ESBL enzymes were initially recognized in clinical isolates in the 1980s; they are derived mainly from the TEM or SHV types of β-lactamases, by point mutations in the parent enzymes which did not possess extended-spectrum β-lactam substrate activity [3, 7] .
More than 200 ESBLs have been identified so far, apart from the TEM, SHV and CTX-M types, other clinically relevant types of ESBLs include the VEB, PER, GES, TLA, IBC, SFO-1, BES-1 and BEL-1 types [7] .
The prevalence of ESBL-producing bacteria has been reported worldwide [8] [9] [10] [11] [12] [13] , while there are a number of publications on ESBL-producing bacteria causing clinical infections [14] [15] [16] [17] [18] [19] in Nigeria, report on the characterization of invasive isolates from infants and children is scanty and since antimicrobial resistance varies greatly among geographical settings, it is crucial to base empiric therapy of severe infections such as BSI on comprehensive knowledge of the prevalence and antimicrobial resistance patterns of locally isolated bacteria. Therefore, the aim of this study was to investigate the genetic composition of ESBL-E from pediatric BSI patients.
Methods

Isolate collection
The study was conducted at 7 hospitals in Federal Capital Territory (FCT) and 3 in Kano Nigeria as previously described from Sept 2008 -Dec 2016 [1, 20] . Children aged less than five years were enrolled at the different sites, blood specimens of 1-3 ml were collected using the vacutainer set, after aseptically cleansing the skin with alcohol swab and povidone-iodine, the specimen was 
Phenotypic screening and confirmation of ESBL
Enterobacteriaceae were identified to the species level using Analytical Profile Index (API 20E) identification strip (Biomeriux Inc, France). Phenotypic ESBL production was confirmed with the combination disc diffusion test with clavulanic acid. CLSI confirmatory test was considered positive when the inhibition zone produced by the discs in combination clavulanate increased ≥5 mm than the disks without the clavulanate (CLSI, 2017), [21] .
Susceptibility was determined using the disk diffusion method on Mueller Hinton agar as recommended by the Clinical and Laboratory Standard Institute (CLSI) (CLSI, 2017), (21) . After completion of the run, a cycle threshold (Ct) was calculated by determining the signal strength at which the fluorescence exceeded a threshold limit. This value was analyzed using the Arial Mx system software version 3.1
Molecular identification of ESBL genes
Statistical analysis
Two-way ANOVA was performed using SPSS V 21 for statistical analysis of data. A p<0.05 was considered statistically significant.
Ethical consideration
Consent was obtained from the International Foundation against Infectious Disease in Nigeria (IFAIN), Abuja to gain access to the stored Enterobacteriaceae obtained between 2009 and 2016.
IFAIN has the written approval by the Research Ethics Committee of all the hospitals in this study.
Results
From Sept 2008-Dec 2016, 21,000 children were screened for bacteremia with a culture positivity rate of 12.5% (2, 625 
Prevalence of ESBLs.
The overall prevalence of ESBL producers observed in this study was 160/413 (38.74%), and the prevalence of ESBL among the isolates were 65.62%, 13.75%, 13.12%, 2.5%, 4.37% and 0.62% 
Antibiotic susceptibility data
Susceptibility profile of the 160 ESBL-producing isolates revealed high resistance rates for Ceftriaxone (92.3%), Aztreonam (96.8%), Cefpodoxime (96.25%), Cefotaxime (98.75%) and sulphamethoxazole-trimethoprim (90%). Over 80% of the isolates were resistant to Cefepime, Amoxicillin clavulanic acid and Ceftazidime (Fig 1) , while 87.5 %, 90.63%, and 91.87% of the isolates were susceptible to Imipenem, Amikacin and Meropenem respectively. Serratia species (Fig 3) . Some of the isolates expressed multiple occurrences of genes, the coexistence of blaCTX-M, blaTEM and blaSHV was seen in 94 of the isolates, while blaCTX-M and blaTEM co-existed in 118 of the isolates, blaTEM and blaSHV in 97 of the isolates while blaCTX-M and blaSHV in 100 of the isolates. Two Escherichia coli isolates expressed ESBL phenotype but no blaTEM, blaSHV or blaCTX-M was detected by PCR.
bla gene composition of ESBL-producing strains
Discussion
ESBLs have become a widespread serious problem and these enzymes are becoming increasingly expressed by many strains of pathogenic bacteria [23] . The rate of ESBL-producing Enterobacteriacea in our study was 38.74% and the isolates were multi drug resistant. ESBL producing isolates showed a higher degree of antimicrobial resistance as compared to non-ESBL producers. Carbapenem and aminoglycosides were shown to be the most effective antimicrobials for ESBL and Non ESBL isolates. In comparison with non ESBL, there was a significant difference in the antibiotic resistance pattern (P= 0.0004; p>0.05).
From our study, it was observed that there were more ESBL isolates from FCT compared to Kano; this probably might be due to the affordability and access to third generation cephalosporins in FCT. Few studies have investigated the prevalence and genetic characteristics of ESBL producing University Teaching Hospital [26] . Also, a study by Adeyankinnu et al., 2014 reported an ESBL prevalence of 26.4% for all isolates tested, with E. coli having a greater proportion [27] . Their study was restricted to detect the presence of ESBL in Escherichia coli and Klebsiella pneumoniae isolates by phenotypic means only.
The data from our study have demonstrated that there is a high prevalence of blaTEM, blaCTX-M, and blaSHV ESBL genes in Enterobacteriaceae isolates. A study from South Eastern Nigeria reported blaCTX-M-15 genes from urine, vaginal and wound swabs of out-patients younger than 30 years [28] . Two studies conducted in Western Nigeria by Olowe et al., [29] from blood, wound, HVS, and sputum samples and Raji et al., [30] from blood, Urine and wound samples revealed the isolates harbored blaCTX-M-1 and blaCTX-M-15 genes respectively.
According to our study, blaTEM and blaCTX-M type were the most prevalent ESBL encoding genes, detected in 83% of the ESBL-producing Enterobacteriaceae and the majority were found in Klebsiella isolates, in contrast to our study, Mohammed et al., from North Eastern Nigeria reported blaSHV (36.4%) and blaTEM (31.4%) to be the most prevalent [31] , although there is a variation in the study design in that our study source of sample was only blood while Mohammed et al., used various specimen [31] . The detection of CTX-M, TEM and SHV genes by molecular techniques in ESBL producing bacteria can supply useful data about their epidemiology, association with epidemic clones and risk factors associated with these infections.
The results from our study however, reflect the global trend toward a pandemic spread of CTX-M-type ESBLs in various Enterobacteriaceae. These findings agree with other contemporary studies from around the world that show that ESBL genes of the CTX-M are dominant in Tanzania, Burkina Faso, Texas, Spain, Brazil, Latin America, [32] [33] [34] [35] [36] [37] . In similarity to our findings, Ahmed et al. [38] reported that blaTEM was the most frequent β-lactamase-encoding gene in Egypt.
In the present study, it was observed that there were multiple occurrences of genes in some of the isolates, this finding is similar to a study in Peru by Garcia et al., where majority (57.3%) of the ESBL strains harbored 2 or more ESBL genes [39] while in Turkey, Bali et al., observed that about 19.2% ESBL isolates carried more than one type of beta lactamases genes [40] .
There were 2 isolates that had none of the genes tested for in them from this study, this may be due to the presence of ESBL genes other than TEM, SHV and CTX-M.
In conclusion, our findings suggest a high prevalence of ESBL resistance to commonly-used antibiotics in Enterobacteriaceae bacteremia in children in this study. Further studies on the transmission dynamics of resistance genes could help in the control of ESBL resistance in these settings.
